Stock Scorecard



Stock Summary for Quanterix Corp (QTRX) - $6.56 as of 3/31/2025 2:24:50 PM EST

Total Score

12 out of 30

Safety Score

37 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for QTRX

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for QTRX

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for QTRX

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for QTRX

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for QTRX (37 out of 100)

Stock Price Rating (Max of 10) 4
Historical Stock Price Rating (Max of 10) 8
Stock Price Trend (Max of 10) 1
Book Value (Max of 10) 4
Book Value to Price (Max of 10) 8
Analyst Buy Ratings (Max of 5) 3
Analyst Strong Buy Ratings (Max of 5) 3
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 6
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for QTRX

Goldman Sachs To Rally Around 8%? Here Are 10 Top Analyst Forecasts For Tuesday - Akoya Biosciences ( NASDAQ:AKYA ) , Artiva Biotherapeutics ( NASDAQ:ARTV ) 3/25/2025 3:11:00 PM
Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results - Akoya Biosciences ( NASDAQ:AKYA ) , Quanterix ( NASDAQ:QTRX ) 3/17/2025 8:00:00 PM
Zynex Inc. ( ZYXI ) Reports Q4 Loss, Misses Revenue Estimates 3/11/2025 9:35:00 PM
BioLife Solutions, Inc. ( BLFS ) Reports Q4 Loss, Tops Revenue Estimates 3/3/2025 1:10:00 PM
QuantumSi Set to Report Q4 Earnings: Buy, Sell or Hold the Stock? 2/26/2025 4:52:00 PM
Bragar Eagel & Squire, P.C. Is Investigating Quanterix, e.l.f. Beauty, and Silvaco and Encourages Investors to Contact the Firm - e.l.f. Beauty ( NYSE:ELF ) , Quanterix ( NASDAQ:QTRX ) 2/25/2025 2:00:00 AM
Neurogen Biomarking Announces Global Agreement with Quanterix for Use of Blood Biomarker Assay in its Patient-Initiated Blood Test to Support Early Detection of Dementia and Mild Cognitive Impairment Due to Alzheimer's Disease 2/19/2025 1:30:00 PM
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IVAC, AVTE, QTRX on Behalf of Shareholders - Aerovate Therapeutics ( NASDAQ:AVTE ) , Intevac ( NASDAQ:IVAC ) 2/17/2025 5:07:00 PM
$TOCKHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger - EVGR, QTRX, RKDA, EBTC 2/14/2025 11:30:00 PM
Quanterix Corporation Announcement: If You Have Suffered Losses in Quanterix Corporation ( NASDAQ: QTRX ) , You Are Encouraged to Contact The Rosen Law Firm About Your Rights - Quanterix ( NASDAQ:QTRX ) 2/14/2025 10:48:00 PM

Financial Details for QTRX

Company Overview

Ticker QTRX
Company Name Quanterix Corp
Country USA
Description Quanterix Corporation, a life sciences company, develops and markets digital immunoassay platforms that advance precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the regions from Asia Pacific. The company is headquartered in Billerica, Massachusetts.
Sector Name LIFE SCIENCES
Industry Name LABORATORY ANALYTICAL INSTRUMENTS
Most Recent Quarter 12/31/2024
Next Earnings Date 5/5/2025

Stock Price History

Last Day Price 6.56
Price 4 Years Ago 42.40
Last Day Price Updated 3/31/2025 2:24:50 PM EST
Last Day Volume 515,291
Average Daily Volume 742,870
52-Week High 23.86
52-Week Low 6.30
Last Price to 52 Week Low 4.13%

Valuation Measures

Trailing PE N/A
Industry PE 34.17
Sector PE 40.10
5-Year Average PE -23.39
Free Cash Flow Ratio 0.88
Industry Free Cash Flow Ratio 1,670.96
Sector Free Cash Flow Ratio 47.05
Current Ratio Most Recent Quarter 8.66
Total Cash Per Share 7.46
Book Value Per Share Most Recent Quarter 8.56
Price to Book Ratio 0.83
Industry Price to Book Ratio 999.63
Sector Price to Book Ratio 21.92
Price to Sales Ratio Twelve Trailing Months 1.98
Industry Price to Sales Ratio Twelve Trailing Months 4.36
Sector Price to Sales Ratio Twelve Trailing Months 27.78
Analyst Buy Ratings 2
Analyst Strong Buy Ratings 1

Share Statistics

Total Shares Outstanding 38,776,200
Market Capitalization 254,371,872
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth -35.89%
Reported EPS 12 Trailing Months -0.95
Reported EPS Past Year -1.03
Reported EPS Prior Year -0.86
Net Income Twelve Trailing Months -38,531,000
Net Income Past Year -38,531,000
Net Income Prior Year -28,354,000
Quarterly Revenue Growth YOY 11.40%
5-Year Revenue Growth 19.36%
Operating Margin Twelve Trailing Months -33.40%

Balance Sheet

Total Cash Most Recent Quarter 289,109,000
Total Cash Past Year 289,109,000
Total Cash Prior Year 328,217,000
Net Cash Position Most Recent Quarter 287,166,000
Net Cash Position Past Year 281,421,000
Long Term Debt Past Year 7,688,000
Long Term Debt Prior Year 7,688,000
Total Debt Most Recent Quarter 1,943,000
Equity to Debt Ratio Past Year 0.98
Equity to Debt Ratio Most Recent Quarter 0.99
Total Stockholder Equity Past Year 330,038,000
Total Stockholder Equity Prior Year 349,958,000
Total Stockholder Equity Most Recent Quarter 330,038,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months -38,532,000
Free Cash Flow Per Share Twelve Trailing Months -0.99
Free Cash Flow Past Year -38,532,000
Free Cash Flow Prior Year -22,637,000

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.32
MACD Signal -0.35
20-Day Bollinger Lower Band 5.67
20-Day Bollinger Middle Band 9.42
20-Day Bollinger Upper Band 13.17
Beta 1.34
RSI 43.18
50-Day SMA 12.42
150-Day SMA 16.32
200-Day SMA 22.95

System

Modified 3/28/2025 5:40:44 AM EST